PC
BIAF icon

Parrish Capital’s bioAffinity Technologies BIAF Stock Holding History

Parrish Capital’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.46K Buy
+695
New +$21.3K 0.01% 87

Other funds holding BIAF

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Parrish Capital's BIAF Position: Q2 2026 in Review

Parrish Capital opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 695 shares worth $8.46K. The stake represents 0.01% of the portfolio and ranks #87 among its holdings.

19 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Parrish Capital held 695 shares of bioAffinity Technologies worth $8.46K as of Q2 2026.
  • bioAffinity Technologies was a new Parrish Capital position in Q2 2026.
  • bioAffinity Technologies made up 0.01% of Parrish Capital's portfolio in Q2 2026, its #87 holding.
  • 19 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Parrish Capital's 13F filing for Q2 2026, filed 1 Sep 2026.